Molecular basis for rational construction of RVGP modified liposomal delivery system targeting to brain

doi:10.5246/jcps.2019.07.047

Abstract

Abstract:

The rational construction of active targeting liposomes will provide an important structural support for its effective brain targeting. However, there is no clear understanding of the structure-activity relationship of active targeting liposomes. Combining multiscale computational simulation and experimental verification, we established a computational model of RVGP modified PEGylated liposomes (RVGP-PEG-L) and investigated the role of PEG and molecular interaction mechanism of carrier-ligand-receptor. The result indicated that the complex network conformation formed by PEG with 42 monomers (42PEG) above the density of 8% was the molecular basis for PEG-L to achieve long-circulation function. The lowest monomer number of PEG linker to ensure the targeting ability of RVGP was 42. However, the pose of RVGP binding to nAChR changed after it was linked with PEG-L due to the restraint of PEG chain, leading to a decrease of binding free energy. Increasing the monomer number of PEG linker or improving the non-polarity of polymers was a potential strategy to enhance the combination of RVGP-PEG-L with nAChR on the targeting cell.

Key words: Multiscale dynamic simulation, Liposomes, Molecular interaction mechanism, Rational construction

CLC Number:

R943

Supporting:

Bo Deng, Wei Cui, Shuang Ma, Xiaona Liu, Zhan Zhang, Baiyi Yan, Kun Chen, Ying Xie. Molecular basis for rational construction of RVGP modified liposomal delivery system targeting to brain[J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(7): 484-501.

References

[1] Uchida, Y.; Ohtsuki, S.; Katsukura, Y.; Ikeda, C.; Suzuki, T.; Kamiie, J.; Terasaki, T. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J. Neurochem. 2011, 117, 333-345.

[2] Jones, A.R.; Shusta, E.V. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm. Res. 2007, 24, 1759-1771.

[3] Liu, C.; Liu, X.N.; Wang, G.L.; Hei, Y.; Meng, S.; Yang, L.F.; Yuan, L.; Xie, Y. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells. Int. J. Nanomedicine. 2017, 12, 2407-2425.

[4] Kumar, P.; Wu, H.Q.; McBride, J.L.; Jung, K.E.; Kim, M.H.; Davidson, B.L.; Lee, S.K.; Shankar, P.; Manjunath, N. Transvascular delivery of small interfering RNA to the central nervous system. Nature. 2007, 448, 39-43.

[5] Blume, G.; Cevc, G.; Crommelin, M.D.; Bakker-Woudenberg, I.A.; Kluft, C.; Storm, G. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim. Biophys. Acta. 1993, 1149, 180-184.

[6] Gref, R.; Lück, M.; Quellec, P.; Marchand, M.; Dellacherie, E.; Harnisch, S.; Blunk, T.; Müller, R.H. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces. 2000, 18, 301-313.

[7] Stefanick, J.F.; Ashley, J.D.; Kiziltepe, T.; Bilgicer, B. A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. ACS Nano. 2013, 7, 2935-2947.

[8] Abe, K.; Higashi, K.; Watabe, K.; Kobayashi, A.; Limwikrant, W.; Yamamoto, K.; Moribe, K. Effects of the PEG molecular weight of a PEG-lipid and cholesterol on PEG chain flexibility on liposome surfaces. Colloids Surf A: Physicochem. Eng. Aspects. 2015, 474, 63-70.

[9] Varga, Z.; Wacha, A.; Vainio, U.; Gummel, J.; Bóta, A. Characterization of the PEG layer of sterically stabilized liposomes: a SAXS study. Chem. Phys. Lipids. 2012, 165, 387-392.

[10] Meng, S.; Cui, W.; Lin, S.H.; Wang, G.L.; Hei, Y.; Deng, B.; Ma, S.; Zhang, Z.; Liu, Y.C.; Xie, Y. Modeling the molecular interactions of budesonide with bovine serum albumin guides the rational preparation of nanoparticles for pulmonary delivery. J. Chin. Pharm. Sci. 2018, 27, 415-428.

[11] Lehtinen, J.; Magarkar, A.; Stepniewski, M.; Hakola, S.; Bergman, M.; Róg, T.; Yliperttula, M.; Urtti, A.; Bunker, A. Analysis of cause of failure of new targeting peptide in PEGylated liposome: molecular modeling as rational design tool for nanomedicine. Eur. J. Pharm. Sci. 2012, 46, 121-130.

[12] Ramezanpour, M.; Leung, S.S.; Delgado-Magnero, K.H.; Bashe, B.Y.; Thewalt, J.; Tieleman, D.P. Computational and experimental approaches for investigating nanoparticle-based drug delivery systems. Biochim. Biophys. Acta. 2016, 1858, 1688-1709.

[13] Marrink, S.J.; Risselada, H.J.; Yefimov, S.; Tieleman, D.P.; de Vries, A.H. The MARTINI force field: coarse grained model for biomolecular simulations. J. Phys. Chem. B. 2007, 111, 7812-7824.

[14] Lee, H.; Pastor, R.W. Coarse-grained model for PEGylated lipids: effect of PEGylation on the size and shape of self-assembled structures. J. Phys. Chem. B. 2011, 115, 7830-7837.

[15] de Jong, D.H.; Singh, G.; Bennett, W.F.; Arnarez, C.; Wassenaar, T.A.; Schäfer, L.V.; Periole, X.; Tieleman, D.P.; Marrink, S.J. Improved parameters for the martini coarse-grained protein force field. J. Chem. Theory. Comput. 2013, 9, 687-697.

[16] Martínez, L.; Andrade, R.; Birgin, E.G.; Martínez, J.M. PACKMOL: A package for building initial configurations for molecular dynamics simulations. J. Comput. Chem. 2009, 30, 2157-2164.

[17] Chaban, V. Computationally efficient prediction of area per lipid. Chem. Phys. Lett. 2014, 616-617, 25-29.

[18] Seelig, A.; Seelig, J. The dynamic structure of fatty acyl chains in a phospholipid bilayer measured by deuterium magnetic resonance. Biochemistry. 1974, 13, 4839-4845.

[19] Lewis, M.; Rees, D.C. Fractal surfaces of proteins. Science. 1985, 230, 1163-1165.

[20] Lee, H.; Larson, R.G. Adsorption of plasma proteins onto PEGylated lipid bilayers: the effect of PEG size and grafting density. Biomacromolecules. 2016, 17, 1757-1765

[21] Humphrey, W.; Dalke, A.; Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 1996, 14, 33-38, 27-28.

[22] Kumari, R.; Kumar, R.; Lynn, A. G_mmpbsa: A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inf. Model. 2014, 54, 1951-1962.

[23] Dennington, R.D.; Keith, T.A.; Millam, J.M. GaussView 5.0. 8. Gaussian Inc. 2008.

[24] Frisch, M.; Trucks, G.; Schlegel, H.; Scuseria, G.; Robb, M.; Cheeseman, J.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. Gaussian 09; Gaussian, Inc. Wallingford CT. 2009, 6492.

[25] Wang, J.M.; Wolf, R.M.; Caldwell, J.W.; Kollman, P.A.; Case, D.A. Development and testing of a general amber force field. J. Comput. Chem. 2004, 25, 1157-1174.

[26] Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M.C.; Xiong, G.M.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T.; Caldwell, J.; Wang, J.M.; Kollman, P. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 2003, 24, 1999-2012.

[27] Szoka, F. Jr, Papahadjopoulos, D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA. 1978, 75, 4194-4198.

[28] Dipali, S.R.; Kulkarni, S.B.; Betageri, G.V. Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods. J. Pharm. Pharmacol. 1996, 48, 1112-1115.

[29] Tristram-Nagle, S.; Zhang, R.; Suter, R.M.; Worthington, C.R.; Sun, W.J.; Nagle, J.F. Measurement of chain tilt angle in fully hydrated bilayers of gel phase lecithins. Biophys. J. 1993, 64, 1097-1109.

[30] Damodaran, V.B.; Fee, C.J.; Ruckh, T.; Popat, K.C. Conformational studies of covalently grafted poly(ethylene glycol) on modified solid matrices using X-ray photoelectron spectroscopy. Langmuir. 2010, 26, 7299-7306.

[31] Peracchia, M.T.; Vauthier, C.; Passirani, C.; Couvreur, P.; Labarre, D. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. Life Sci. 1997, 61, 749-761.

[32] Garbuzenko, O.; Barenholz, Y.; Priev, A. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. Chem. Phys. Lipids. 2005, 135, 117-129.

[33] Rabanel, J.M.; Hildgen, P.; Banquy, X. Assessment of PEG on polymeric particles surface, a key step in drug carrier translation. J. Control. Release. 2014, 185, 71-87.